Manufacturer of Controlled Substances; Notice of Application; Agilent Technologies, 30025-30026 [2012-12268]
Download as PDF
<![CDATA[
30025
Federal Register / Vol. 77, No. 98 / Monday, May 21, 2012 / Notices
Dated: May 16, 2012.
Benjamin J. Robinson,
Deputy Rules Officer and Counsel.
Washington, DC 20544, telephone (202)
502–1820.
Dated: May 16, 2012.
Benjamin J. Robinson,
Deputy Rules Officer and Counsel.
[FR Doc. 2012–12255 Filed 5–16–12; 4:15 pm]
BILLING CODE 2210–55–P
[FR Doc. 2012–12266 Filed 5–16–12; 4:15 pm]
JUDICIAL CONFERENCE OF THE
UNITED STATES
BILLING CODE 2210–55–P
Meeting of the Judicial Conference
Advisory Committee on Rules of
Bankruptcy Procedure
DEPARTMENT OF JUSTICE
Judicial Conference of the
United States.
ACTION: Notice of open meeting.
Importer of Controlled Substances;
Notice of Application; Stepan
Company
Drug Enforcement Administration
AGENCY:
The Advisory Committee on
Rules of Bankruptcy Procedure will
hold a two-day meeting. The meeting
will be open to public observation but
not participation.
DATES: September 20–21, 2012.
Time: 8:30 a.m. to 5 p.m.
ADDRESSES: Hotel Monaco Portland, 506
SW Washington Street, Portland, OR
97204.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Benjamin J. Robinson, Deputy Rules
Officer and Counsel, Administrative
Office of the United States Courts,
Washington, DC 20544, telephone (202)
502–1820.
Dated: May 16, 2012.
Benjamin J. Robinson,
Deputy Rules Officer and Counsel.
[FR Doc. 2012–12258 Filed 5–16–12; 4:15 pm]
BILLING CODE 2210–55–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Meeting of the Judicial Conference
Committee on Rules of Practice and
Procedure
Judicial Conference of the
United States.
ACTION: Notice of open meeting.
AGENCY:
The Committee on Rules of
Practice and Procedure will hold a twoday meeting. The meeting will be open
to public observation but not
participation.
SUMMARY:
June 11–12, 2012.
Time: 8:30 a.m. to 5 p.m.
ADDRESSES: Thurgood Marshall Federal
Judiciary Building, Mecham Conference
Center, One Columbus Circle NE.,
Washington, DC 20544.
FOR FURTHER INFORMATION CONTACT:
Benjamin J. Robinson, Deputy Rules
Officer and Counsel, Administrative
Office of the United States Courts,
ebenthall on DSK5SPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
18:18 May 18, 2012
Jkt 226001
This is notice that on February 27,
2012, Stepan Company, Natural
Products Department, 100 W. Hunter
Avenue, Maywood, New Jersey 07607,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
Coca Leaves (9040), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
applicants for registration to import a
basic class of any controlled substance
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12248 Filed 5–18–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Formulation
Technologies, LLC
By Notice dated January 26, 2012, and
published in the Federal Register on
February 6, 2012, 77 FR 5845,
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Formulation Technologies, LLC., 11501
Domain Drive, Suite 130, Austin, Texas
78758, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Fentanyl (9801), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance for analytical
research and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Formulation Technologies, LLC. to
import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Formulation Technologies, LLC. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12241 Filed 5–18–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Agilent Technologies
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 11, 2012,
Agilent Technologies, 25200
Commercentre Drive, Lake Forest,
California 92630–8810, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
Drug
Phencyclidine (7471) ....................
E:\FR\FM\21MYN1.SGM
21MYN1
Schedule
II
30026
Federal Register / Vol. 77, No. 98 / Monday, May 21, 2012 / Notices
Drug
Schedule
1-Piperidinocyclohexane- .............
carbonitrile (8603) .....................
Benzoylecgonine (9180) ...............
II
II
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 20, 2012.
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application,
Ampac Fine Chemicals LLC.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 11, 2012,
AMPAC Fine Chemicals LLC., Highway
50 and Hazel Avenue, Building 05001,
Rancho Cordova, California 95670,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Schedule
ebenthall on DSK5SPTVN1PROD with NOTICES
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
II
II
The company is a contract
manufacturer. In reference to Poppy
Straw Concentrate the company will
manufacture Thebaine intermediates for
sale to its customers for further
manufacture. No other activity for this
drug code is authorized for registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
VerDate Mar<15>2010
19:32 May 18, 2012
Jkt 226001
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12277 Filed 5–18–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice Of Application;
Stepan Company
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on February 28, 2012,
Stepan Company, Natural Products
Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
DEPARTMENT OF JUSTICE
Drug
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Noramco Inc. (GA)
[FR Doc. 2012–12268 Filed 5–18–12; 8:45 am]
Drug
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 20, 2012.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 21, 2012,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Gamma Hydroxybutyric Acid (2010), a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 20, 2012.
Dated: May 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12282 Filed 5–18–12; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Cocaine (9041) .............................
Ecgonine (9180) ...........................
Schedule
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 20, 2012.
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12286 Filed 5–18–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Johnson Matthey, Inc.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 26, 2012,
Johnson Matthey, Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, made application by letter
to the Drug Enforcement Administration
(DEA) to be registered as a bulk
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 77, Number 98 (Monday, May 21, 2012)]
[Notices]
[Pages 30025-30026]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12268]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Agilent Technologies
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 11, 2012, Agilent
Technologies, 25200 Commercentre Drive, Lake Forest, California 92630-
8810, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phencyclidine (7471)....................... II
[[Page 30026]]
1-Piperidinocyclohexane-................... II
carbonitrile (8603).......................
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 20, 2012.
Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-12268 Filed 5-18-12; 8:45 am]
BILLING CODE 4410-09-P
